Sangamo Therapeutics
SGMO
$0.41
Share price
-17.30%
Change (1 day)
-63.40%
Change (1 year)
Market capitalization of Sangamo Therapeutics (SGMO)
Market cap: $85.82 Million
As of June 2024 Sangamo Therapeutics has a market cap of $85.82 Million. This makes Sangamo Therapeutics the world's 7570th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Sangamo Therapeutics from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $85.82 M | -10.92% |
| 2023 | $96.35 M | -81.28% |
| 2022 | $0.51 B | -52.9% |
| 2021 | $1.09 B | -50.5% |
| 2020 | $2.20 B | 127.38% |
| 2019 | $0.97 B | -17.26% |
| 2018 | $1.17 B | -15.37% |
| 2017 | $1.38 B | 543.51% |
| 2016 | $0.21 B | -66.47% |
| 2015 | $0.64 B | -38.85% |
| 2014 | $1.05 B | 21.5% |
| 2013 | $0.86 B | 171.12% |
| 2012 | $0.31 B | 113.99% |
| 2011 | $0.14 B | -50.54% |
| 2010 | $0.30 B | 13.12% |
| 2009 | $0.26 B | 86.78% |
| 2008 | $0.14 B | -72.83% |
| 2007 | $0.52 B | 126.96% |
| 2006 | $0.23 B | 87.74% |
| 2005 | $0.12 B | -18.75% |
| 2004 | $0.15 B | 11.08% |
| 2003 | $0.13 B | 83.3% |
| 2002 | $74.46 M | -67.43% |
| 2001 | $0.22 B |
End of Day market cap according to different sources
On Jun 17th, 2024 the market cap of Sangamo Therapeutics was reported to be:
$85.82 Million
$85.82 Million
$85.82 Million
$85.14 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $351.25 B | 409,163.37% | 🇺🇸 USA |
 Amgen AMGN | $162.69 B | 189,457.65% | 🇺🇸 USA |
 Biogen BIIB | $32.97 B | 38,317.08% | 🇺🇸 USA |
 Dow DOW | $38.83 B | 45,152.03% | 🇺🇸 USA |
 Gilead Sciences GILD | $80.07 B | 93,194.16% | 🇺🇸 USA |
 Merck MRK | $322.93 B | 376,164.48% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $19.89 B | 23,083.14% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $16.14 B | 18,709.65% | 🇺🇸 USA |